Newspaper article from our research archive:
|
|
Shire Development.(DDMAC)
- Article from:
-
Warning Letter Bulletin
- Article date:
-
June 1, 2008
|
Copyright informationCOPYRIGHT 2008 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Wayne, PA, May 1 (DDMAC)
The Division of Drug Marketing, Advertising, and Communications (DDMAC) reviewed a Notebook (FOS1598) and a Medical Exam Light Case (FOS1597) submitted by Shire Development for Fosrenol (lanthanum carbonate) and determined the items violative "because although they have the form of reminder labeling," which is exempted by regulation from the requirements for the disclosure of risk and other information, "we have determined that your promotional materials are not appropriate reminder labeling."
Therefore, the pieces misbrand Fosrenol in violation of regulations because they fail to include the drug product's indication, as well as contextual ...
|
The FDA regulatory methods validation program for new and abbreviated new...
Pharmaceutical Technology;
January 1, 2000 ;
Layloff, T; Nasr, M; Baldwin, R; Caphart, M; Et al;
787 words
......consistent standards for drug substances and drug product regardless of the synthesis and manufacturing...purity, and potency of an approved new drug product. This article provides an overview of...acceptable quality of the drug substance and drug product throughout its shelf life ...
|
|
WISCONSIN: Rep. Musser Introduces Bill Relating to Substitution of...
US Fed News Service, Including US State News;
March 7, 2007 ;
272 words
......prescribed or, if the price is lower, a drug product that the federal Food and Drug Administration...equivalent of the drug prescribed (drug product equivalent). Currently, a pharmacist may not substitute a drug product equivalent if a prescription indicates...
|
|
Identification and Risk-Assessment of Extractables and Leachables
Pharmaceutical Technology;
January 1, 2006 ;
Kauffman, Jon S;
787 words
......can make informed decisions regarding drug product purity and safety. An area of increasing...concern, 21 CFR 211.94 a) states that: Drug product containers and closures shall not be...These compounds can contaminate the drug product. Leachables are compounds that leach...
|
|
Smith Labs sells its sole drug product to Baxter
Chicago Sun-Times;
July 24, 1986 ;
Susan Chandler;
247 words
......Smith Laboratories said yesterday it is selling its only drug product to Baxter Travenol in Deerfield. The sale includes all marketing...orthopedic product company. Sales of Chymodiactin, Smith's only drug product, were hurt following reports of paralysis among patients...
|
|
Changing the supply-chain controls for excipients, part II: The...
Pharmaceutical Technology;
October 1, 2000 ;
Silverstein, Irwin B;
787 words
......recognized the need for communication to keep drug product makers informed of significant change...excipient would cause a change in the drug product. However, by the time a drug manufacturer...associated with the adverse effect on the drug product that results from the change in ...
|
|
Emerlyn Technology Introduces OneScan(TM) Dynamic Purchasing System to...
PR Newswire;
June 14, 2006 ;
392 words
......hand-held barcode scanner that simplifies drug product ordering for pharmacists and complements...their cost of goods. OneScan scans drug product from multiple vendors and transfers...daily to help pharmacists make optimal drug product purchases. On the web at http://www...
|
|
A comprehensive approach to pharmaceutical engineering training
Pharmaceutical Technology North America;
December 1, 2001 ;
Glasser, Benjamin J; Cole, Jack; Muzzio, Fernando J;
787 words
......money. On average, introducing a new drug product to market takes approximately 15 years and $650 million. A drug product consists of therapeutics and excipients combined in a delivery system. A drug product's success lies in its ability to deliver...
|
|
Purdue Expert Says U.S. Has Low Risk of Receiving Contaminated Drugs.
AScribe Medicine News Service;
April 28, 2008 ;
642 words
......elements are incorporated into a final drug product. The U.S. Food and Drug Administration...drug substance and manufacture of the drug product. The second step is usually performed...United States and incorporated into the drug product - the actual tablet or injection a person...
|
|
FDA debarment.(Federal Regulation)
Drug Detection Report;
October 30, 2003 ;
155 words
......services in any capacity to anyone who has a pending or approved drug product application, effective Oct. 20: Reasons: Courtney, a pharmacist...million in restitution. Anyone with a pending or approved drug product application who knowingly uses Courtney's services is subject...
|
|
GMPs Demystified : Be proactive by assuring full compliance with cGMPs as...
Global Cosmetic Industry;
June 1, 2001 ;
Geffken, Carl;
787 words
......processing, packing, and holding of any OTC drug product is compliance with a set of directives...in the manufacture and handling of a drug product is expected to have documented qualifications...validation. Control of Components and Drug Product Containers and Closures--Written ...
|
|
Forced degradation of ibuprofen in bulk drug and tablets and determination...
Pharmaceutical Technology North America;
May 1, 2002 ;
Farmer, Sherri; Anderson, Pamela; Burns, Philip; Velagaleti, Ranga;
787 words
......about how the quality of bulk drug or drug product varies with time under the influence...evaluating the stability of drug substance or drug product should be specific and selective and...quantitative changes in drug substance and drug product over time (2). The specificity and ...
|
|
INCOME RISES FOR GENZYME, STAPLES
The Boston Globe;
March 6, 1998 ;
Ronald Rosenberg;
273 words
......year-end financial results and strong growth in its largest drug product were not enough to prevent Genzyme General's stock from tumbling...it's very hard to get excited . . . there is no very large drug product on the horizon," said Dr. Charles B. Engelberg, director...
|
|
Research and Markets: The major emphasis in drug product development in...
M2 Presswire;
January 6, 2005 ;
787 words
......Research and Markets: The major emphasis in drug product development in these competitive times...specifications. The major emphasis in drug product development in these competitive times...according to the stage of development of the drug product, but a similar approach may be ...
|
|
Think Safety and Use Common Sense to Meet New IND GMP Regulations
Biopharm International;
April 1, 2006 ;
Taylor, James A;
596 words
......Title 21 CFR Part 211) that refers to drug product manufacturing; they extend, by implication...facilities, produce initial batches of drug product. In practice, the regulations apply...sponsors in the production of API and drug product as well. In determining where to apply...
|
See all results.
Or, try our
Advanced Search.
|